Results 241 to 250 of about 61,000 (287)
DEN Open, Volume 6, Issue 1, April 2026.Abstract Objectives Most esophageal cancers in Japan are squamous cell carcinomas; however, there has been some concern regarding a recent increase in Barrett's esophageal adenocarcinoma (BEA). This study aimed to clarify the clinical characteristics and outcomes of patients treated via endoscopic submucosal dissection (ESD) in Kyushu, including ...
Fumisato Sasaki +29 more
wiley +1 more source
DEN Open, Volume 6, Issue 1, April 2026.Abstract Objectives Esophagogastroduodenoscopy (EGD) is vital for diagnosing and treating upper gastrointestinal symptoms, but patient discomfort and anxiety can affect procedural outcomes. This study aimed to compare the effectiveness of topical analgesics with and without Entonox during EGD in terms of procedural success, patient tolerance, and ...
Papiroon Noitasaeng +3 more
wiley +1 more source
DEN Open, Volume 6, Issue 1, April 2026.Abstract Introduction Gastrointestinal cancers account for 26% of cancer incidence and 35% of cancer‐related deaths globally. Early detection is crucial but often limited by white light endoscopy (WLE), which misses subtle lesions. Texture and color enhancement imaging (TXI), introduced in 2020, enhances texture, brightness, and color, addressing WLE's
Muhammad Shahzil +10 more
wiley +1 more source
Gastroesophageal Reflux as a Possible Result of Clozapine Treatment
, 1998 Robert W. Baker, K. N. Roy Chengappa
openalex +2 more sources
DEN Open, Volume 6, Issue 1, April 2026.Abstract Gastric abscess is a rare condition caused by gastric barrier damage. It is easily misdiagnosed in clinical practice as a cancer recurrence or submucosal tumor, especially after surgery or endoscopic submucosal dissection. With a relatively high mortality rate, the cause and clinical characteristics of gastric abscesses are obscure.
Jia Xie, Mo‐Jin Wang, Rui Wang
wiley +1 more source
DEN Open, Volume 6, Issue 1, April 2026.Abstract Background and aims Endoscopic anti‐reflux therapies like anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation have shown efficacy for gastroesophageal reflux disease (GERD) in systematic reviews and meta‐analyses. Anti‐reflux mucoplasty (ARM‐P), a refinement of ARMS, incorporates immediate closure of the resection site to reduce ...
Kazuki Yamamoto +11 more
wiley +1 more source
DEN Open, Volume 6, Issue 1, April 2026.Abstract Endoscopic antireflux therapy is a novel endoscopic treatment for refractory gastroesophageal reflux disease. We developed antireflux myoplasty (AR‐MP), a modified version of antireflux mucoplasty (ARM‐P), in which exposed bilateral sling fibers are sutured directly via endoscopic hand‐suturing.
Hironari Shiwaku +9 more
wiley +1 more source
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Objectives A ‘gray color sign’ (GCS) is a new endoscopic feature of fundic gland polyp associated with proton pump inhibitor (PPI‐FGP). Here, we compare the ability of texture and color enhancement imaging (TXI) to white light imaging (WLI) with regard to the detection of GCS. Methods In this prospective study, 19 consecutive patients with PPI‐
Ryota Uchida +17 more
wiley +1 more source
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Introduction Anti‐reflux mucosectomy (ARMS) and anti‐reflux mucosal ablation (ARMA) are novel endoscopic treatments for proton pump inhibitor or potassium‐competitive acid blocker‐refractory gastroesophageal reflux disease. These procedures induce scarring of the artificial ulcer at the gastric cardia, which tightens the enlarged cardiac ...
Ippei Tanaka +8 more
wiley +1 more source